Cargando…
β-arrestin1/YAP/mutant p53 complexes orchestrate the endothelin A receptor signaling in high-grade serous ovarian cancer
The limited clinical response observed in high-grade serous ovarian cancer (HG-SOC) with high frequency of TP53 mutations (mutp53) might be related to mutp53-driven oncogenic pathway network. Here we show that β-arrestin1 (β-arr1), interacts with YAP, triggering its cytoplasmic-nuclear shuttling. Th...
Autores principales: | Tocci, Piera, Cianfrocca, Roberta, Di Castro, Valeriana, Rosanò, Laura, Sacconi, Andrea, Donzelli, Sara, Bonfiglio, Silvia, Bucci, Gabriele, Vizza, Enrico, Ferrandina, Gabriella, Scambia, Giovanni, Tonon, Giovanni, Blandino, Giovanni, Bagnato, Anna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6642155/ https://www.ncbi.nlm.nih.gov/pubmed/31324767 http://dx.doi.org/10.1038/s41467-019-11045-8 |
Ejemplares similares
-
miR-30a inhibits endothelin A receptor and chemoresistance in ovarian carcinoma
por: Sestito, Rosanna, et al.
Publicado: (2015) -
YAP and endothelin-1 signaling: an emerging alliance in cancer
por: Tocci, Piera, et al.
Publicado: (2021) -
Targeting endothelin 1 receptor-miR-200b/c-ZEB1 circuitry blunts metastatic progression in ovarian cancer
por: Sestito, Rosanna, et al.
Publicado: (2020) -
hMENA is a key regulator in endothelin-1/β-arrestin1–induced invadopodial function and metastatic process
por: Di Modugno, Francesca, et al.
Publicado: (2018) -
Nuclear β-arrestin1 is a critical cofactor of hypoxia-inducible factor-1α signaling in endothelin-1-induced ovarian tumor progression
por: Cianfrocca, Roberta, et al.
Publicado: (2016)